Monday 24 February 2020

DNA Sequencing market growth and regional forecast 2019 - 2025

Market Scenario
The global DNA sequencing market is expected to grow significantly over the forecast period. It is estimated that the DNA sequencing market is expected to register a CAGR of ~ 17.64 % during the forecast period from 2018 to 2023.
The DNA sequencing method is used to determine the order of the nucleotide bases adenine, guanine, cytosine, and thymine in a molecule of DNA. The DNA sequencing market is driven by factors such as growing requirement of breeders for animals and plant production, development in technology, increasing research and development, growing prevalence of cancer, and growth in liquid biopsy applications. New market players get attracted towards the global DNA sequencing market, as a lot of research is taking place in DNA sequencing market. The increasing prevalence of cancer is boosting the DNA sequencing market globally. In addition, increasing use of genome mapping programs globally and R&D investments boost the market growth.  
However, accuracy and standardization concern and ethical and legal limitations associated with DNA Sequencing Market may hinder the market growth.
DNA Sequencing Market Key players
Key players in the global DNA Sequencing Market are Perkin Elmer, Roche Holdings AG, Siemens AG, Illumina, Agilent Technologies Inc., Genia Corporation, Oxford Nanopore technologies, Koninklijke Philips N.V., Pacific Biosciences, Johnson & Johnson, Deep Genomics, Inc., Life Technologies, Illumina, Eppendorf, Tecan, Thermo Scientific, Hamilton Thorne Biosciences, General Electric Company, Siemens Healthineers GmbH, Myriad Genetics, Bayer Corporation, Beckman Coulter, and others.
DNA Sequencing Market Segmentation
The global DNA sequencing market has been segmented on basis of type, product, technology, application, and end-users. On the basis of type, the DNA Sequencing Market is segmented into instruments and consumables services and workflow products. Based on products, the DNA Sequencing Market is segmented into sequencing services and sequencing instruments and consumables. Sequencing instruments and consumables are further sub-segmented into two types, namely, sequencing instruments and consumables by product type and by platform type. Sequencing instruments and consumables, by product type, are further sub-segmented into consumables and instruments, whereas sequencing instruments and consumables, by platform type, are further sub-segmented into NGS, sanger, bioinformatics, sample prep kits, and reagents. On the basis of technology, the DNA Sequencing Market is further segmented into semiconductor sequencing, pyrosequencing, sequencing by synthesis, single-molecule real-time sequencing (SMRT), sequencing by ligation (SBL), and other technologies. On the basis of application, the DNA Sequencing Market is further segmented into diagnostics, agriculture and animal research, biomarker discovery, personalized medicine, drug discovery, and other applications. Based on end-user, the DNA Sequencing Market is segmented into research centers and government institutes and academia, biotechnology and pharmaceutical companies, clinics and hospitals, and other end-users.
DNA Sequencing Market Regional Summary
The DNA Sequencing Market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The DNA sequencing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European DNA sequencing market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The DNA sequencing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The DNA sequencing market in the Middle East and Africa has been segmented into the Middle East and Africa.
On the basis of region, the DNA Sequencing Market is segmented into North America, Europe, Asia-Pacific, and the Middle East and Africa. The North American market is anticipated to dominate the DNA sequencing market due to the rising prevalence of cancer among the geriatric population, developed innovation ecology, large buying power, and the presence of major players.
Europe is anticipated to drive the growth of the DNA Sequencing Market in the upcoming years due to increasing incidences of an aging population suffering from cancer, sedentary lifestyle, and an efficient reimbursement scenario.
Asia-Pacific is projected to register a robust growth in the coming years due to large patient population and growing healthcare infrastructure and expenditure.
The Middle East and Africa is expected to account for the lowest market share in the global DNA Sequencing Market due to the lack of advanced technology and poor medical facilities in developing economies in this region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

No comments:

Post a Comment